These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. An intracellular anti-erbB-2 single-chain antibody is specifically cytotoxic to human breast carcinoma cells overexpressing erbB-2. Wright M; Grim J; Deshane J; Kim M; Strong TV; Siegal GP; Curiel DT Gene Ther; 1997 Apr; 4(4):317-22. PubMed ID: 9176517 [TBL] [Abstract][Full Text] [Related]
4. Targeted eradication of ovarian cancer mediated by intracellular expression of anti-erbB-2 single-chain antibody. Deshane J; Cabrera G; Grim JE; Siegal GP; Pike J; Alvarez RD; Curiel DT Gynecol Oncol; 1995 Oct; 59(1):8-14. PubMed ID: 7557620 [TBL] [Abstract][Full Text] [Related]
5. Remission of human breast cancer xenografts on therapy with humanized monoclonal antibody to HER-2 receptor and DNA-reactive drugs. Pietras RJ; Pegram MD; Finn RS; Maneval DA; Slamon DJ Oncogene; 1998 Oct; 17(17):2235-49. PubMed ID: 9811454 [TBL] [Abstract][Full Text] [Related]
6. Effective single chain antibody (scFv) concentrations in vivo via adenoviral vector mediated expression of secretory scFv. Arafat WO; Gómez-Navarro J; Buchsbaum DJ; Xiang J; Wang M; Casado E; Barker SD; Mahasreshti PJ; Haisma HJ; Barnes MN; Siegal GP; Alvarez RD; Hemminki A; Nettelbeck DM; Curiel DT Gene Ther; 2002 Feb; 9(4):256-62. PubMed ID: 11896464 [TBL] [Abstract][Full Text] [Related]
7. Adenovirus-mediated calponin h1 gene therapy directed against peritoneal dissemination of ovarian cancer: bifunctional therapeutic effects on peritoneal cell layer and cancer cells. Ogura T; Kobayashi H; Ueoka Y; Okugawa K; Kato K; Hirakawa T; Hashimoto S; Taniguchi S; Wake N; Nakano H Clin Cancer Res; 2006 Sep; 12(17):5216-23. PubMed ID: 16951241 [TBL] [Abstract][Full Text] [Related]
8. Transductional efficacy and safety of an intraperitoneally delivered adenovirus encoding an anti-erbB-2 intracellular single-chain antibody for ovarian cancer gene therapy. Deshane J; Siegal GP; Wang M; Wright M; Bucy RP; Alvarez RD; Curiel DT Gynecol Oncol; 1997 Mar; 64(3):378-85. PubMed ID: 9062138 [TBL] [Abstract][Full Text] [Related]
9. A cancer gene therapy approach utilizing an anti-erbB-2 single-chain antibody-encoding adenovirus (AD21): a phase I trial. Alvarez RD; Barnes MN; Gomez-Navarro J; Wang M; Strong TV; Arafat W; Arani RB; Johnson MR; Roberts BL; Siegal GP; Curiel DT Clin Cancer Res; 2000 Aug; 6(8):3081-7. PubMed ID: 10955787 [TBL] [Abstract][Full Text] [Related]
10. Combined transcriptional and transductional targeting improves the specificity and efficacy of adenoviral gene delivery to ovarian carcinoma. Barker SD; Dmitriev IP; Nettelbeck DM; Liu B; Rivera AA; Alvarez RD; Curiel DT; Hemminki A Gene Ther; 2003 Jul; 10(14):1198-204. PubMed ID: 12833129 [TBL] [Abstract][Full Text] [Related]
11. An adenovirus encoding proapoptotic Bax induces apoptosis and enhances the radiation effect in human ovarian cancer. Arafat WO; Gómez-Navarro J; Xiang J; Barnes MN; Mahasreshti P; Alvarez RD; Siegal GP; Badib AO; Buchsbaum D; Curiel DT; Stackhouse MA Mol Ther; 2000 Jun; 1(6):545-54. PubMed ID: 10933979 [TBL] [Abstract][Full Text] [Related]
12. Intracellular single-chain antibody directed against erbB2 down-regulates cell surface erbB2 and exhibits a selective anti-proliferative effect in erbB2 overexpressing cancer cell lines. Deshane J; Loechel F; Conry RM; Siegal GP; King CR; Curiel DT Gene Ther; 1994 Sep; 1(5):332-7. PubMed ID: 7584099 [TBL] [Abstract][Full Text] [Related]
13. Mutant SV40 large T antigen as a therapeutic agent for HER-2/neu-overexpressing ovarian cancer. Xing X; Matin A; Yu D; Xia W; Sorgi F; Huang L; Hung MC Cancer Gene Ther; 1996; 3(3):168-74. PubMed ID: 8725881 [TBL] [Abstract][Full Text] [Related]
14. The tumor suppression activity of E1A in HER-2/neu-overexpressing breast cancer. Chang JY; Xia W; Shao R; Sorgi F; Hortobagyi GN; Huang L; Hung MC Oncogene; 1997 Feb; 14(5):561-8. PubMed ID: 9053854 [TBL] [Abstract][Full Text] [Related]
15. Adenoviral-mediated delivery of gastrin-releasing peptide receptor results in specific tumor localization of a bombesin analogue in vivo. Rosenfeld ME; Rogers BE; Khazaeli MB; Mikheeva G; Raben D; Mayo MS; Curiel DT; Buchsbaum DJ Clin Cancer Res; 1997 Jul; 3(7):1187-94. PubMed ID: 9815798 [TBL] [Abstract][Full Text] [Related]
16. Molecular chemotherapy combined with radiation therapy enhances killing of cholangiocarcinoma cells in vitro and in vivo. Pederson LC; Buchsbaum DJ; Vickers SM; Kancharla SR; Mayo MS; Curiel DT; Stackhouse MA Cancer Res; 1997 Oct; 57(19):4325-32. PubMed ID: 9331094 [TBL] [Abstract][Full Text] [Related]
17. Visualization of effective tumor targeting by CD8+ natural killer T cells redirected with bispecific antibody F(ab')(2)HER2xCD3. Scheffold C; Kornacker M; Scheffold YC; Contag CH; Negrin RS Cancer Res; 2002 Oct; 62(20):5785-91. PubMed ID: 12384539 [TBL] [Abstract][Full Text] [Related]
19. E1A-mediated paclitaxel sensitization in HER-2/neu-overexpressing ovarian cancer SKOV3.ip1 through apoptosis involving the caspase-3 pathway. Ueno NT; Bartholomeusz C; Herrmann JL; Estrov Z; Shao R; Andreeff M; Price J; Paul RW; Anklesaria P; Yu D; Hung MC Clin Cancer Res; 2000 Jan; 6(1):250-9. PubMed ID: 10656456 [TBL] [Abstract][Full Text] [Related]
20. Specific tumoricidal activity of a secreted proapoptotic protein consisting of HER2 antibody and constitutively active caspase-3. Jia LT; Zhang LH; Yu CJ; Zhao J; Xu YM; Gui JH; Jin M; Ji ZL; Wen WH; Wang CJ; Chen SY; Yang AG Cancer Res; 2003 Jun; 63(12):3257-62. PubMed ID: 12810656 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]